In the background of Covid-19, there is an urgent requirement for hand sanitisers across the U.S. Huntsman will donate the first 5-tonne shipment of hand sanitiser to Huntsman Cancer Institute and the associated medical facilities at the University of Utah to help protect the frontline workers treating coronavirus patients.

AGC Pharma Chemicals Europe aims to increase pharmaceutical production capacity by 1.3 times that of the current level with this expansion. A new R&D facility is also expected to be constructed as a part of this project.

An underperforming dust collector is often the result of very high dust loading, ineffective cleaning, or a combination of the two. Left unchecked, these problems can result in unplanned downtime and increased operating costs. So, while this is not necessarily an exhaustive rollout of potential issues, listed below you will find a handy checklist of measures you and your staff can take to avoid costly shutdowns and frequent filter changes.

Sabic just signed a memorandum of understanding with Chinese businesses and authorities for a new thermoplastics compound facility in Chongquing, Western China.

Claris Lifesciences Ltd, India (Claris) has announced the completion of the transfer of its Infusion business for India and Emerging Markets to the Joint Venture (Claris-Otsuka) with Otsuka Pharmaceutical Factory Inc, Japan (OPF) and Mitsui & Co Ltd, Japan (Mitsui).

Jacobs will provide engineering, procurement and construction management (EPCM) services for the construction of a vinyl acetate ethylene (VAE) emulsions production plant at Jurong Island, Singapore.

Lukoil announced that it has taken the final investment decision on the delayed coker complex at Nizhny Novgorod refinery. The complex includes the construction of the delayed coker unit itself, the diesel hydro treatment unit, the gas fractionation unit, the sulfur and hydrogen production units and other infrastructure. The designed capacity of the complex is 2.1 million tonnes per annum.

Sasol has succesfully started–up Phase I of its Fischer-Tropsch Wax Expansion Project (FTWEP) at Sasolburg, South Africa. Pahe 2 is already underway.

The company has entered into a Stock Purchase Agreement with a wholly owned subsidiary of Cardinal Health. The base payment for the transaction is 1.2 billion dollars.

The International Society for Pharmaceutical Engineering’s Facility of the Year Awards Programme recognises unique projects that make use of innovative technologies in order to enhance the quality of products and processes in the pharma sector.